slides · global inventory
Authority Citation
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,176
Current window 1,171-1,200
Pages 73
Rows per page 30
Framework
1,171-1,200 of 2,176
09
The slide uses expert testimony and competitor insight to build a bearish thesis on GTT's operational health.GTT Communications, Inc. (GTT) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Pattern Hunter1 hit
12
The slide contains a direct quote from a legal judgment regarding misappropriation of assets.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Loop · Cost Of Inaction1 hit
24
Page 24 of 33. Combines a video-still illustration, narrative prose, a block pull-quote from EH's 20-F, and concluding analytical paragraph.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
29
Page 29 of 33. Table evidences a related-party financing scheme; Chinese-language screenshots paired with English translations of Plaintiff, Cause, Court, and Defendant fields.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
42
The slide relies heavily on anecdotal evidence from industry executives and field engineers to support the thesis of market exhaustion.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
49
The slide uses expert quotes to build a narrative of competitive displacement and regulatory pressure.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
51
The slide uses a 'Q&A' format to document expert interviews, highlighting the lack of choice for customers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
61
The slide uses direct quotes from KOLs to build a case against the company's pricing model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
103
The slide uses expert testimony to build a case for high customer concentration and potential ethical/business risks.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
116
Contains highlighted text segments within the quotes.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
178
The slide uses expert quotes to argue that off-label use of perfusion pumps is limited by reputational risk and biological constraints.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
278
The slide uses a Q&A format to build a narrative of market abandonment.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
295
The slide uses a direct quote from a surgeon to undermine the credibility and clinical utility of the TransMedics OCS device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
304
The slide uses direct quotes from surgeons to build a bearish case against the company (TransMedics/Waleed).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
315
The slide uses direct quotes from a transplant surgeon to validate the thesis that TransMedics is at risk of being rendered obsolete by competitors.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
316
Includes verbatim transcripts from a transplant surgeon regarding competitive dynamics in the liver transplant market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
325
The slide uses a direct quote to frame the current market situation as overpriced and vulnerable to disruption, drawing an analogy to the Hepatitis C drug market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
335
The slide uses a Q&A format to highlight a specific failure in the procurement process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
17
This slide uses a series of numbered testimonials to build a case against the company's business model.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Exposing contradictions in Twist's narrative1 hit
36
Uses highlighted text to emphasize key accusations of IP theft and unethical behavior.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
63
Uses Q&A format to highlight expert testimony.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Presentation of the thesis1 hit
72
Uses expert quotes to frame Twist's business model as unsustainable compared to competitors.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
97
The slide uses a Q&A format to build credibility for the core thesis of operational failure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
177
The slide uses Q&A transcripts to undermine the competitive moat of the subject company (Twist).Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
178
The slide uses a Q&A format to frame the expert's testimony as a critique of Twist's business model.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
191
The slide uses a Q&A format to present expert testimony.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
193
The slide uses highlighted text to emphasize key negative sentiment regarding Twist's market position.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
195
Uses expert testimony to frame the company as a commodity player in a niche market.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
205
The slide uses a Q&A format to validate the thesis that Twist faces an existential threat from new market entrants.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
207
The slide uses expert testimony to frame Twist as vulnerable to both established incumbents and new, cheaper technologies.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit